Targacept, Inc.Winston-Salem, NC, United States (NASDAQ (GM): TRGT)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Targacept Financial Statements

Targacept Financial Information

Company Type Public
Single Location
Fiscal Year-End December
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Targacept Income Statement

  2007 2006 2005
Revenue ($ mil.) 11.6 27.5 1.2
Gross Profit ($ mil.) 10.9 27.1 0.7
Operating Income ($ mil.) (31.8) (0.4) (29.9)
Total Net Income ($ mil.) (28.1) 2.1 (29.0)
Diluted EPS (Net Income) (1.42) (0.09) (153.54)
More Targacept financial information

Targacept Stock Quote & Chart

10/10/08 15:00:11 EST • NASDAQ • 5.26 • Increased by +2.4400 • Increased by +86.5248 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Targacept Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 13.92 3.31 1.48
Price/Earnings Ratio -- 14.57 15.28
Price/Book Ratio 3.24 2.76 1.45
Price/Cash Flow Ratio 137.40 12.29 9.29
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Targacept Financial Ratios

Targacept Competitive Intelligence

Abbott Labs Memory Pharmaceuticals Pfizer
Annual Sales ($ mil.) 25,914.2 11.5 48,418.0
Employees 68,000 55 86,600
Market Cap ($ mil.) 90,057.2 25.5 122,955.7

Competitive Landscape